packageGlecaprevirAndPibrentasvir

glecaprevir and pibrentasvir

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Glecaprevir/pibrentasvir is a combination antiviral medicine used to treat hepatitis C. It is an approved direct-acting antiviral for HCV infections.

Summary written by glm-5.3-flash from Wikidata Q39048038 and the WHO ATC classification; not checked by a person.

name:glecaprevir and pibrentasvir
ATC codes:J05AP57
DrugBank:DB13878
Wikidata:Q39048038
molar mass:1952 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown